Clinical Trials Directory

Trials / Unknown

UnknownNCT02578784

DEB-after-Cutting Balloon-PTA in Dialysis Fistula Stenosis

Prospective, Randomized Trial on the Clinical Utility of Drug-coated Balloons After Angioplasty of Plain Old Balloon-resistent Dialysis Fistula Stenosis Using Cutting Ballons

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Cantonal Hospital of St. Gallen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The incidence of hemodynamically relevant dialysis fistula stenoses/obstructions after 1 year is between 60-90% (from 62.5 to 91% radiocephalic, brachiocephalic 70-84%, PTFE shunts 62-87%), necessitating a therapeutic measure to preserve dialysis access during this period in 1/3 of the patients. This therapeutic measure is a dilatation of the stenosis using a standard PTA balloon (POBA, plain old balloon angioplasty with a primary technical success rate of 50-79% \[2-4\].In turn, in 21-50% of the cases an insufficient PTA result is obtained (so-called POBA-resistant stenosis). In these cases, predilatation with a so-called cutting balloon (carrying with small knives on its surface) is performed, leading to a success rate of 89%. However, a problem is the high incidence of restenosis, which is about 40% for recurrent stenosis and over 10% in de novo stenosis. The use of drug-coated balloon (DCB) in non-POBA resistant stenoses lead to a reduction in the restenosis rate of 35% to 5%. However, the effect of DCB in POBA resistant stenoses is unknown. Therefore, the aim of this study is to evaluate the clinical benefit of the combined use of a cutting balloon and a drug-coated balloon in POBA resistant dialysis fistula stenoses compared to the sole use of a cutting balloon.

Conditions

Interventions

TypeNameDescription
DEVICEAngioplasty with drug-coated balloonAngioplasty with drug-coated balloon "Elutax" (Aachen Resonance, Germany)
DEVICEAngioplasty with plain old balloonAngioplasty with plain old balloon "Sterling" (BostonScientific, Switzerland)

Timeline

Start date
2015-10-01
Primary completion
2017-10-01
Completion
2018-10-01
First posted
2015-10-19
Last updated
2015-10-19

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02578784. Inclusion in this directory is not an endorsement.